• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非甾体类抗炎药类作为神经退行性疾病的潜在治疗药物。

Fenamates as Potential Therapeutics for Neurodegenerative Disorders.

机构信息

Department of Biomedical and Pharmaceutical Sciences, University of Rhode Island, Kingston, RI 02881, USA.

Interdisciplinary Neuroscience Program, University of Rhode Island, Kingston, RI 02881, USA.

出版信息

Cells. 2021 Mar 22;10(3):702. doi: 10.3390/cells10030702.

DOI:10.3390/cells10030702
PMID:33809987
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8004804/
Abstract

Neurodegenerative disorders are desperately lacking treatment options. It is imperative that drug repurposing be considered in the fight against neurodegenerative diseases. Fenamates have been studied for efficacy in treating several neurodegenerative diseases. The purpose of this review is to comprehensively present the past and current research on fenamates in the context of neurodegenerative diseases with a special emphasis on tolfenamic acid and Alzheimer's disease. Furthermore, this review discusses the major molecular pathways modulated by fenamates.

摘要

神经退行性疾病的治疗方法严重匮乏。在对抗神经退行性疾病的过程中,必须考虑药物再利用。芬那酸类药物已被研究用于治疗几种神经退行性疾病。本综述的目的是全面介绍过去和目前关于神经退行性疾病中芬那酸类药物的研究,特别强调托芬那酸和阿尔茨海默病。此外,本综述还讨论了芬那酸类药物调节的主要分子途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e38b/8004804/a3d2be51584c/cells-10-00702-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e38b/8004804/761f9c272dbe/cells-10-00702-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e38b/8004804/8a66228f2a02/cells-10-00702-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e38b/8004804/a3d2be51584c/cells-10-00702-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e38b/8004804/761f9c272dbe/cells-10-00702-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e38b/8004804/8a66228f2a02/cells-10-00702-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e38b/8004804/a3d2be51584c/cells-10-00702-g003.jpg

相似文献

1
Fenamates as Potential Therapeutics for Neurodegenerative Disorders.非甾体类抗炎药类作为神经退行性疾病的潜在治疗药物。
Cells. 2021 Mar 22;10(3):702. doi: 10.3390/cells10030702.
2
Mechanistic new insights of flavonols on neurodegenerative diseases.黄酮醇对神经退行性疾病作用机制的新见解。
Biomed Pharmacother. 2021 May;137:111253. doi: 10.1016/j.biopha.2021.111253. Epub 2021 Feb 2.
3
Multiple actions of fenamates and other nonsteroidal anti-inflammatory drugs on GABA receptors.芳基烷酸类和其他非甾体抗炎药对 GABA 受体的多种作用。
Eur J Pharmacol. 2019 Jun 15;853:247-255. doi: 10.1016/j.ejphar.2019.03.039. Epub 2019 Mar 28.
4
Effects of non-steroidal anti-inflammatory drugs on polymorphonuclear leukocyte functions in vitro: focus on fenamates.非甾体抗炎药对体外多形核白细胞功能的影响:聚焦于灭酸类药物。
Naunyn Schmiedebergs Arch Pharmacol. 1994 Dec;350(6):685-91. doi: 10.1007/BF00169375.
5
Environmental photochemistry of fenamate NSAIDs and their radical intermediates.非甾体抗炎药芬那酸类及其自由基中间体的环境光化学
Environ Sci Process Impacts. 2017 May 24;19(5):656-665. doi: 10.1039/c7em00079k.
6
Neuroprotective offerings by agmatine.精氨酸的神经保护作用。
Neurotoxicology. 2019 Jul;73:228-245. doi: 10.1016/j.neuro.2019.05.001. Epub 2019 May 4.
7
Fenamates as TRP channel blockers: mefenamic acid selectively blocks TRPM3.非甾体抗炎药作为 TRP 通道阻滞剂:甲芬那酸选择性地阻断 TRPM3。
Br J Pharmacol. 2011 Apr;162(8):1757-69. doi: 10.1111/j.1476-5381.2010.01186.x.
8
Iron chelation and neuroprotection in neurodegenerative diseases.铁螯合与神经退行性疾病的神经保护。
J Neural Transm (Vienna). 2011 Mar;118(3):473-7. doi: 10.1007/s00702-010-0518-0. Epub 2010 Dec 16.
9
Fenamates inhibit human sodium channel Nav1.7 and Nav1.8.非甾体抗炎芬那酸盐类药物抑制人类钠通道Nav1.7和Nav1.8。
Neurosci Lett. 2019 Mar 23;696:67-73. doi: 10.1016/j.neulet.2018.12.008. Epub 2018 Dec 5.
10
Fenamates protect neurons against ischemic and excitotoxic injury in chick embryo retina.非甾体抗炎芬那酸类药物可保护鸡胚视网膜神经元免受缺血性和兴奋性毒性损伤。
Neurosci Lett. 1998 Feb 20;242(3):163-6. doi: 10.1016/s0304-3940(98)00081-0.

引用本文的文献

1
Recent Advances and Future Directions in Alzheimer's Disease Genetic Research.阿尔茨海默病遗传研究的最新进展与未来方向
Int J Mol Sci. 2025 Aug 13;26(16):7819. doi: 10.3390/ijms26167819.
2
Pleiotropic Effects of the NSAID Fenamates on Chloride Channels: Opportunity for Ion Channelopathies?非甾体抗炎药芬那酸盐对氯离子通道的多效性作用:离子通道病的契机?
Pharmacol Res Perspect. 2025 Aug;13(4):e70144. doi: 10.1002/prp2.70144.
3
Photolysis of tolfenamic acid in aqueous and organic solvents: a kinetic study.托芬那酸在水性和有机溶剂中的光解:一项动力学研究。

本文引用的文献

1
The involvement of NLRP3 inflammasome in the treatment of Alzheimer's disease.NLRP3 炎性小体在阿尔茨海默病治疗中的作用。
Ageing Res Rev. 2020 Dec;64:101192. doi: 10.1016/j.arr.2020.101192. Epub 2020 Oct 13.
2
Integrated Pathways of COX-2 and mTOR: Roles in Cell Sensing and Alzheimer's Disease.COX-2与mTOR的整合通路:在细胞感知及阿尔茨海默病中的作用
Front Neurosci. 2020 Jul 9;14:693. doi: 10.3389/fnins.2020.00693. eCollection 2020.
3
Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective.
RSC Adv. 2024 Jul 8;14(30):21383-21397. doi: 10.1039/d4ra01369g. eCollection 2024 Jul 5.
4
Innovative Therapeutic Strategies in Alzheimer's Disease: A Synergistic Approach to Neurodegenerative Disorders.阿尔茨海默病的创新治疗策略:神经退行性疾病的协同治疗方法
Pharmaceuticals (Basel). 2024 Jun 6;17(6):741. doi: 10.3390/ph17060741.
5
Antiseizure properties of fenamate NSAIDs determined in mature human stem-cell derived neuroglial circuits.在成熟的人类干细胞衍生神经胶质细胞回路中确定的非甾体抗炎药(NSAIDs)的抗癫痫特性。
Front Pharmacol. 2024 May 16;15:1385523. doi: 10.3389/fphar.2024.1385523. eCollection 2024.
6
Tolfenamic Acid Derivatives: A New Class of Transcriptional Modulators with Potential Therapeutic Applications for Alzheimer's Disease and Related Disorders.托芬那酸衍生物:一类新型转录调节剂,有望用于治疗阿尔茨海默病及相关疾病。
Int J Mol Sci. 2023 Oct 16;24(20):15216. doi: 10.3390/ijms242015216.
7
Druggable targets for the immunopathy of Alzheimer's disease.阿尔茨海默病免疫病变的可药物作用靶点。
RSC Med Chem. 2023 Jul 11;14(9):1645-1661. doi: 10.1039/d3md00096f. eCollection 2023 Sep 19.
8
Meclofenamate Suppresses MUC5AC Mucin Gene Expression by Regulating the NF-kB Signaling Pathway in Human Pulmonary Mucoepidermoid NCI-H292 Cells.甲氯芬那酸通过调节人肺黏液表皮样NCI-H292细胞中的NF-κB信号通路抑制MUC5AC黏蛋白基因表达。
Biomol Ther (Seoul). 2023 May 1;31(3):306-311. doi: 10.4062/biomolther.2023.035. Epub 2023 Apr 7.
9
Microglia as a cellular target of diclofenac therapy in Alzheimer's disease.小胶质细胞作为双氯芬酸治疗阿尔茨海默病的细胞靶点。
Ther Adv Neurol Disord. 2023 Feb 27;16:17562864231156674. doi: 10.1177/17562864231156674. eCollection 2023.
非甾体抗炎药(NSAIDs)与器官损伤:当前观点。
Biochem Pharmacol. 2020 Oct;180:114147. doi: 10.1016/j.bcp.2020.114147. Epub 2020 Jul 10.
4
Alleles and Diet in Brain Aging and Alzheimer's Disease.大脑衰老与阿尔茨海默病中的等位基因和饮食
Front Aging Neurosci. 2020 Jun 10;12:150. doi: 10.3389/fnagi.2020.00150. eCollection 2020.
5
Comparison of regional flortaucipir PET with quantitative tau immunohistochemistry in three subjects with Alzheimer's disease pathology: a clinicopathological study.三名患有阿尔茨海默病病理的受试者中,区域氟代脱氧葡萄糖正电子发射断层扫描(flortaucipir PET)与定量tau免疫组织化学的比较:一项临床病理研究
EJNMMI Res. 2020 Jun 15;10(1):65. doi: 10.1186/s13550-020-00653-x.
6
Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options.癫痫耐药性:临床影响、潜在机制和新的创新治疗选择。
Pharmacol Rev. 2020 Jul;72(3):606-638. doi: 10.1124/pr.120.019539.
7
Tolfenamic acid inhibits GSK-3β and PP2A mediated tau hyperphosphorylation in Alzheimer's disease models.托法替布酸抑制阿尔茨海默病模型中 GSK-3β 和 PP2A 介导的 tau 过度磷酸化。
J Physiol Sci. 2020 Jun 9;70(1):29. doi: 10.1186/s12576-020-00757-y.
8
Mefenamic acid can attenuate depressive symptoms by suppressing microglia activation induced upon chronic stress.甲芬那酸可通过抑制慢性应激诱导的小胶质细胞激活来减轻抑郁症状。
Brain Res. 2020 Aug 1;1740:146846. doi: 10.1016/j.brainres.2020.146846. Epub 2020 Apr 20.
9
Enhancing Anti-Tumor Activity of Sorafenib Mesoporous Silica Nanomatrix in Metastatic Breast Tumor and Hepatocellular Carcinoma via the Co-Administration with Flufenamic Acid.通过与氟芬那酸联合给药增强索拉非尼介孔硅纳米基质在转移性乳腺癌和肝癌中的抗肿瘤活性。
Int J Nanomedicine. 2020 Mar 16;15:1809-1821. doi: 10.2147/IJN.S240436. eCollection 2020.
10
2020 Alzheimer's disease facts and figures.2020年阿尔茨海默病事实与数据。
Alzheimers Dement. 2020 Mar 10. doi: 10.1002/alz.12068.